Concepedia

Per Mygind

PM

16

Publications

1.7K

Citations

16

H-Index

1998

Active since

Affiliations

Novozymes (Denmark)(Current)

Aarhus University

Novo Nordisk (Denmark)

Ascendis Pharma (Denmark)

Statens Serum Institut

Per Mygind is an author at Novozymes (Denmark) specializing in medicine, clinical microbiology, and microbiology.

Top concepts

Publications per year

1998–2022

16

Publications

16

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus

Per Mygind, Rikke L. Fischer, Kirk Schnorr et al. · Nature · 2005 · 649 citations

, , +7

Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II

Tanja Schneider, Thomas Kruse, Reinhard Wimmer et al. · Science · 2010 · 540 citations · Full text

Identification of Two Novel Genes Encoding 97- to 99-Kilodalton Outer Membrane Proteins of <i>Chlamydia pneumoniae</i>

A. S. Madsen, Per Mygind, Gunna Christiansen et al. · Infection and Immunity · 1999 · 69 citations · Full text

Analysis of the Humoral Immune Response to<i>Chlamydia</i>Outer Membrane Protein 2

Per Mygind, Gunna Christiansen, Kenneth Persson et al. · Clinical and Diagnostic Laboratory Immunology · 1998 · 60 citations · Full text

TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias

Vibeke Breinholt, C.E. Rasmussen, Per Mygind et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 60 citations · Full text

Rows per page

1–5 of 16